STOCK TITAN

Plus Products Announces Transition of Jennifer Tung from her roles as Chief Risk Officer and General Counsel to Special Advisor to the Board

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Plus Products Inc. (OTCQX: PLPRF) announced the departure of Jennifer Tung as Chief Risk Officer and General Counsel, effective April 15, 2021. Tung, who joined PLUS in September 2018, played a crucial role in navigating the regulatory landscape of the cannabis industry and was integral during the company's IPO. She will continue her association with PLUS as a special advisor to the Board of Directors. CEO Jake Heimark praised her contributions and expressed optimism for the company's future in the evolving cannabis market.

Positive
  • Jennifer Tung's tenure helped navigate complex regulatory challenges.
  • Her role included significant contributions during the company's Initial Public Offering.
  • Tung will continue as a special advisor, ensuring ongoing expertise is available.
Negative
  • None.

SAN MATEO, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the “Company” or “PLUS”), a cannabis and hemp branded products company in the U.S., today announced that Jennifer Tung will be leaving her roles as Chief Risk Officer and General Counsel on April 15, 2021. She will remain a special advisor to the Board of Directors.

Ms. Tung, who joined PLUS in September 2018, has played a key role in the Company as it has navigated the emerging regulatory environment of the legal cannabis industry. She helped guide the Company through its Initial Public Offering and has provided support across the organization on key matters relating to compliance, governance, and general corporate strategy.

“Jen has been an integral part of the PLUS leadership team during her time with the Company,” stated Jake Heimark, Co-Founder and CEO. “It was a pleasure to work with her over the last several years and we wish Jen the best as she heads into the next chapter of her legal career. We are pleased that Jen will continue her association with PLUS by remaining a special advisor to the Board as PLUS continues to operate within the rapidly changing cannabis regulatory landscape.”

“I am proud of what we have accomplished at PLUS over the past three years, and look forward to continuing to advise the company moving forward,” stated Ms. Tung.

About PLUS

PLUS is a hemp and cannabis food company focused on using nature to bring balance to consumers’ lives. PLUS’s mission is to make cannabis safe and approachable – that begins with high-quality products that deliver consistent consumer experiences. PLUS is headquartered in San Mateo, CA.

For further information contact:

Jake Heimark
CEO & Co-founder
ir@plusproducts.com

Investors:

Cole Stewart
Investor Relations 
Cole@plusproducts.com
Tel +1 213.282.6987

Media:

plus@mattio.com
Mattio Communication

The CSE does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This press release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (each, a “forward-looking statement”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur.

These forward-looking statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this press release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the success of the Company’s investments, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of the Company’s products, customer experience and retention, the continued development of adult-use sales channels, managements estimation of consumer demand in in jurisdictions where the Company exports, expectations of future results and expenses, the availability of additional capital to complete capital projects and facilities improvements, the ability to expand and maintain distribution capabilities, the impact of competition, the ability of the Company to implement initiatives and the possibility for changes in laws, rules, and regulations in the industry. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.


FAQ

Who is Jennifer Tung and why is she leaving Plus Products Inc.?

Jennifer Tung is the Chief Risk Officer and General Counsel at Plus Products Inc. She is leaving her roles effective April 15, 2021, but will remain a special advisor to the Board.

What impact might Jennifer Tung's departure have on Plus Products Inc.?

While Tung's departure could impact leadership continuity, her ongoing advisory role may mitigate potential disruptions.

When did Jennifer Tung join Plus Products Inc.?

Jennifer Tung joined Plus Products Inc. in September 2018.

What were Jennifer Tung's contributions to Plus Products Inc.?

Tung played a key role in navigating the regulatory landscape and was instrumental during the company's Initial Public Offering.

What is the current status of Plus Products Inc.?

Plus Products Inc. continues to operate within the evolving cannabis regulatory landscape, focusing on safe and approachable cannabis products.

PLPRF

OTC:PLPRF

PLPRF Rankings

PLPRF Latest News

PLPRF Stock Data

1.81B
39.64M
33.86%
0.09%
Drug Manufacturers—Specialty & Generic
Healthcare
Link
Canada
Vancouver